Reports say Pfizer could be in plans to purchase Elan Corp.
NEW YORK After The Financial Times reported Sunday that Pfizer may buy a large drug maker, speculation has arisen that it might buy Ireland’s Elan Corp.
According to Bloomberg, Elan’s stock price has increased 15 percent on the speculation, but representatives of neither Elan nor Pfizer would comment on the matter.
A number of drug makers have sought to acquire smaller companies in recent months, including Eli Lilly & Co., AstraZeneca and Teva Pharmaceutical Industries. GlaxoSmithKline chief executive officer Andrew Witty told a conference at Goldman Sachs in New York that GSK would also seek acquisitions in 2009 to strengthen its business in developing countries and OTC products, according to published reports.
Liquidia partners with Abbott on genetic disease treatment research
RESEARCH TRIANGLE PARK, N.C. A pharmaceutical company and a nanotechnology company will collaborate to develop particles to deliver short interfering RNA particle therapeutics.
Liquidia Technologies and Abbott announced the collaboration Wednesday, in which they will use Liquidia’s PRINT technology to fabricate nanoparticles of precise shape, size and chemistry to shut off genes associated with certain diseases.
“Delivery has been the most significant hurdle to realizing the broad potential of siRNA therapeutics,” Liquidia CEO Neal Fowler said in a statement. “We are very pleased to form a partnership with Abbott, which we hope will enable significant progress in addressing this problem.”
Under the agreement, Liquidia will provide Abbott with certain rights to PRINT technology for developing and commercializing siRNA therapeutics. The two companies did not disclose financial terms.
PhRMA, health organizations release video ad pushing healthcare reform
WASHINGTON Six organizations representing a broad portion of the U.S. healthcare industry unveiled an advertisement Thursday to promote healthcare reform as a top priority for the incoming Obama Administration and the next Congress.
The Pharmaceutical Research and Manufacturers of America, Regence BlueCross BlueShield, the American Medical Association, the Service Employees International Union, the American Cancer Society Cancer Action Network and Families USA showed the 30-second ad at a press conference at the American Medical Association’s headquarters in Washington Thursday.
The ad focuses on the country’s manufacturing industries, opening with shots of decrepit factories and cobwebbed equipment, followed by shots of working factories with employees. It opens with the line, “At a time when American businesses are hurting, why should we worry about fixing health care? Because quality, affordable health care can save money and make businesses more competitive.”
The organizations plant to run the ad until Feb. 5, possibly later.
“Expanding access to quality and affordable health insurance is good for patients and good for our economy,” PhRMA president and CEO Billy Tauzin said in a statement released with the ad. “Improved access means we can do more to promote prevention and more to detect and treat conditions at an early stage, when we can do the most to avoid poor health outcomes and costly complications of chronic diseases, which account for seven out of every 10 deaths in America.”